LRRK2 G2019S通过NF-κB通路促进由寡合性α-synuclein诱导的星细胞炎症

Kai-Jie He1,2, Jin-Bao Zhang1,2, Jun-Yi Liu3

  • 1Department of Neurology and Clinical Research Center of Neurological Disease, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China.

iScience
|October 25, 2023
PubMed
概括

在帕金森病 (PD) 中,有毒的α-synuclein (O-αS) 和LRRK2突变会恶化神经炎症. 抑制LRRK2激酶活性可以降低这些炎症效应,提供一种潜在的PD治疗策略.